Mark W Hahn Insider Trading $MLNT MELINTA THERAPEUTICS, INC. /NEW/

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Mark W Hahn.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Mark W Hahn. Mark W Hahn is CFO, VP of Finance and Admin in GIGABEAM CORP ($GGBM) and EVP and CFO in CEMPRA, INC. ($CEMP) and Chief Financial Officer in Verona Pharma plc ($VRNA) and Chief Financial Officer in Dova Pharmaceuticals, Inc. ($DOVA).

Mark W Hahn in MELINTA THERAPEUTICS, INC. /NEW/

Trading Symbol: MLNT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark W Hahn: EVP and CFO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 27 2017
$MLNT Market Capitalization: $151.90M
$MLNT Previous Close: $3.00

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Mark W Hahn in MELINTA THERAPEUTICS, INC. /NEW/

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, DOVA, GGBM, MLNT, VRNA

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 27 2017CEMPCEMPRA, INC.Hahn Mark WEVP and CFOOption ExerciseA0.0025,000025,000
Feb 27 2017CEMPCEMPRA, INC.Hahn Mark WEVP and CFOOption ExerciseA3.1525,00078,75025,000
Jan 05 2017CEMPCEMPRA, INC.Hahn Mark WEVP and CFOOption ExerciseA0.0050,000050,000
Jan 05 2017CEMPCEMPRA, INC.Hahn Mark WEVP and CFOOption ExerciseA3.00125,000375,000125,000
Jan 05 2016CEMPCEMPRA, INC.Hahn Mark WEVP and CFOOption ExerciseA31.1359,6601,857,21659,660

Page:   1